Home > Insider Trading > Filing (0001140361-17-035544)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1012477	Avadel Pharmaceuticals Plc	AVDL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410677	J Greg Divis	C/O Avadel Pharmaceuticals Plc Block 10-1 Blanchardstown Corporate Park Dublin L2 15	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Adss	Acquisiton	2017-09-12	10,600	$9.32	10,600	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Adss	Stock Option (right to buy)	$10.40		2026-12-14	150,000	150,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2026-12-14	150,000	150,000	Direct

Footnotes

The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.14 to $9.85, inclusive. The reporting person undertakes to provide to Avadel Pharmaceuticals plc, any security holder of Avadel Pharmaceuticals plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2).
Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.